Qualitative assessment of pertussis diagnostics in United States laboratories

Pediatric Infectious Disease Journal

Volumn 32, Issue 9, 2013, Pages 942-945

  Tatti, Kathleen M ^a   Martin, Stacey W ^a   Boney, Kathryn O ^a   Brown, Kristin ^a   Clark, Thomas A ^a   Tondella, Maria Lucia ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Bordetella spp.; Pertussis diagnostics; Polymerase chain reaction; Proficiency panels

Indexed keywords

ARTICLE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; DATA EXTRACTION; DIAGNOSTIC TEST; E-MAIL; FALSE POSITIVE RESULT; HOSPITAL LABORATORY; INTERNET; LABORATORY; LIMIT OF DETECTION; PERTUSSIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; UNITED STATES;

BORDETELLA PERTUSSIS; CLINICAL LABORATORY TECHNIQUES; DATA COLLECTION; DIAGNOSTIC TESTS, ROUTINE; HUMANS; LABORATORY PROFICIENCY TESTING; QUALITY CONTROL; UNITED STATES; WHOOPING COUGH;

EID: 85047687090     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182947ef8     Document Type: Article

References (24)

1. Guthrie JL, Robertson AV, Tang P, et al. Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with Pertussis-like symptoms in Ontario, Canada. J Clin Microbiol. 2010;48:1435-1437.
2. Njamkepo E, Bonacorsi S, Debruyne M, et al. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J Clin Microbiol. 2011;49:4347-4348.
3. Rodgers L, Martin SW, Cohn A, et al. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis-Ohio, 2010-2011. Clin Infect Dis. 2013;56:322-331.
4. Cherry JD, Seaton BL. Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010. Clin Infect Dis. 2012;54:534-537.
5. Faulkner AE, Skoff TH, Clark TA, et al. Evolution of Pertussis Diagnostic Testing in the U. S.:1995-2009. Presented at: 2011 Council of State and Territorial Epidemiologists Annual Conference. Pittsburgh, PA; 2011.
6. Borst A, Box AT, Fluit AC. False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis. 2004;23:289-299.
7. Centers for Disease Control and Prevention. Outbreaks of respiratory illness mistakenly attributed to pertussis - New Hampshire, Massachusetts, and Tennessee, 2004-2006. JAMA. 2007;298:1999-2002.
8. Mandal S, Tatti KM, Woods-Stout D, et al. Contamination by environmentally present DNA in pediatric clinics results in pertussis pseudo-outbreak. Pediatrics. 2012;129:424-430.
9. Caro V, Guiso N, Alberti C, et al. Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses. J Clin Microbiol. 2009;47:3197-3203.
10. Muyldermans G, Soetens O, Antoine M, et al. External quality assessment for molecular detection of Bordetella pertussis in European laboratories. J Clin Microbiol. 2005;43:30-35.
11. Riffelmann M, Wirsing Von Konig CH, Caro Y et al.; Pertussis PCR Consesus Group. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol. 2005;43:4925-4929.
12. He Q, Barkoff AM, Mertsola J, et al.; European Bordetella expert group (EUpertstrain); European surveillance network for vaccine-preventable diseases (EUVAC. NET). High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill. 2012;17:20239.
13. Hardwick TH, Plikaytis B, Cassiday PK, etal. Reproducibility of Bordetella pertussis genomic DNA fragments generated by Xbal restriction and resolved by pulsed-fleld gel electrophoresis. J Clin Microbiol. 2002;40:811-816.
14. Tatti KM, Sparks KN, Boney KO, et al. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol. 2011;49:4059-4066.
15. Riffelmann M, Thiel K, Schmetz J, et al. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol. 2010;48:4459-4463.
16. Tondella ML, Carlone GM, Messonnier N, et al. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine. 2009;27:803-814.
17. Tatti KM, Wu KH, Tondella ML, et al. Development and evaluation of dualtarget real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Microbiol Infect Dis. 2008;61:264-272.
18. Vincart B, De Mendonca R, Rottiers S, et al. A specific real-time PCR assay for the detection of Bordetella pertussis. J Med Microbiol. 2007;56(Pt 7):918-920.
19. Kallonen T, Mertsola J, Mooi FR, et al. Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clin Microbiol Infect. 2012;18:E377-E379.
20. Barkoff AM, Mertsola J, Guillot S, et al. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol. 2012;19:1703-1704.
21. Bouchez V, Brun D, Cantinelli T, et al. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine. 2009;27:6034-6041.
22. Otsuka N, Han HJ, Toyoizumi-Ajisaka H, et al. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One. 2012;7:e31985.
23. Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013;368:583-584.
24. Menzies SL, Kadwad Y Pawloski LC, et al.; Pertussis Assay Working Group. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin Vaccine Immunol. 2009;16:1781-1788.